English
Back
Download
Log in to access Online Inquiry
Back to the Top

$Vertex Pharmaceuticals (VRTX.US)$ & $CRISPR Therapeutics (C...

$Vertex Pharmaceuticals (VRTX.US)$ & $CRISPR Therapeutics (CRSP.US)$
📣 Announces CASGEVY™ (exagamglogene autotemcel) FDA approval on 01/16🥳

⇒ Treatment of transfusion-dependent beta-thalassemia (TDT) in patients 12 yrs and older👏

⇒ One-time treatment⭐

ℹ️ Drug info:
• CASGEVY™ (exagamglogene autotemcel [exa-cel])

⇒ PDUFA goal date: 3/30/24
⇒ BLA
⇒ Transfusion-dependent beta-thalassemia (TDT)
⇒ CRISPR/Cas9 gene-edited cell therapy
$Vertex Pharmaceuticals (VRTX.US)$ & $CRISPR Therapeutics (CRSP.US)$ 📣 Announces CASGEVY™ (exagamglogene autotemcel) FDA approval on 01/16🥳  ⇒ Treatment of tr...
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
7
+0
Translate
Report
235K Views
Comment
Sign in to post a comment